Come up with a name for your new list and we'll add to it:
Sangamo Therapeutics raised a round of funding on January 12, 2001. Investors include
AAC Capital Partners.
Sangamo Therapeuticsm aka Sangamo BioSciences, of Richmond, CA, is focused on the research and development of novel transcription factors for the regulation of gene expression. The company's most adva…